STERIS generated $5.8B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $707.8M with a 12.15% net margin. Gross margin stands at 44.11% and operating margin at 17.18%. Diluted EPS is $7.16, which grew 0.5% year-over-year. Based on the Q4 2025 filing.